Suivre
Pr Sandrine Lablanche
Pr Sandrine Lablanche
CHUGA - UGA
Adresse e-mail validée de chu-grenoble.fr
Titre
Citée par
Citée par
Année
Closed-loop insulin delivery in adults with type 1 diabetes in real-life conditions: a 12-week multicentre, open-label randomised controlled crossover trial
PY Benhamou, S Franc, Y Reznik, C Thivolet, P Schaepelynck, E Renard, ...
The Lancet Digital Health 1 (1), e17-e25, 2019
1832019
Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a …
S Lablanche, MC Vantyghem, L Kessler, A Wojtusciszyn, S Borot, ...
The lancet Diabetes & endocrinology 6 (7), 527-537, 2018
1612018
Five-Year Metabolic, Functional, and Safety Results of Patients With Type 1 Diabetes Transplanted With Allogenic Islets Within the Swiss-French GRAGIL Network
BPY Lablanche S1, Borot S2, Wojtusciszyn A3, Bayle F4, Tétaz R4, Badet L5 ...
Diabetes Care, 2015
1332015
Inhibition of complex I regulates the mitochondrial permeability transition through a phosphate-sensitive inhibitory site masked by cyclophilin D
B Li, C Chauvin, D De Paulis, F De Oliveira, A Gharib, G Vial, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1817 (9), 1628-1634, 2012
1202012
Efficacy and safety of suspend-before-low insulin pump technology in hypoglycaemia-prone adults with type 1 diabetes (SMILE): an open-label randomised controlled trial
E Bosi, P Choudhary, HW De Valk, S Lablanche, J Castañeda, S De Portu, ...
The lancet Diabetes & endocrinology 7 (6), 462-472, 2019
1062019
Protection of pancreatic INS-1 β-cells from glucose-and fructose-induced cell death by inhibiting mitochondrial permeability transition with cyclosporin A or metformin
S Lablanche, C Cottet-Rousselle, F Lamarche, PY Benhamou, S Halimi, ...
Cell death & disease 2 (3), e134-e134, 2011
932011
Impact of sleep behavior on glycemic control in type 1 diabetes: the role of social jetlag
S Larcher, AS Gauchez, S Lablanche, JL Pépin, PY Benhamou, AL Borel
European journal of endocrinology 175 (5), 411-419, 2016
802016
Diabeloop DBLG1 closed-loop system enables patients with type 1 diabetes to significantly improve their glycemic control in real-life situations without serious adverse events …
C Amadou, S Franc, PY Benhamou, S Lablanche, E Huneker, ...
Diabetes Care 44 (3), 844-846, 2021
622021
Indications for islet or pancreatic transplantation: Statement of the TREPID working group on behalf of the Société francophone du diabète (SFD), Société francaise d …
A Wojtusciszyn, J Branchereau, L Esposito, L Badet, F Buron, ...
Diabetes & metabolism 45 (3), 224-237, 2019
462019
Use of dipeptidyl peptidase‐4 inhibitors and prognosis of COVID‐19 in hospitalized patients with type 2 diabetes: A propensity score analysis from the CORONADO study
R Roussel, P Darmon, M Pichelin, T Goronflot, Y Abouleka, L Ait Bachir, ...
Diabetes, Obesity and Metabolism 23 (5), 1162-1172, 2021
392021
Anti-donor HLA antibody response after pancreatic islet grafting: characteristics, risk factors, and impact on graft function
E Pouliquen, P Baltzinger, A Lemle, CC Chen, A Parissiadis, S Borot, ...
American Journal of Transplantation 17 (2), 462-473, 2017
362017
Angio-oedema induced by dual dipeptidyl peptidase inhibitor and angiotensin II receptor blocker: a first case report
S Skalli, N Wion-Barbot, M Baudrant, S Lablanche, P Benhamou, S Halimi
Diabetic Medicine 27 (4), 486-487, 2010
312010
Respective effects of oxygen and energy substrate deprivation on beta cell viability
S Lablanche, C Cottet-Rousselle, L Argaud, C Laporte, F Lamarche, ...
Biochimica et Biophysica Acta (BBA)-Bioenergetics 1847 (6-7), 629-639, 2015
302015
Practical implementation of automated closed-loop insulin delivery: a French position statement
N Tubiana-Rufi, P Schaepelynck, S Franc, L Chaillous, M Joubert, ...
Diabetes & Metabolism 47 (3), 101206, 2021
262021
Human mesenchymal stem cells improve rat islet functionality under cytokine stress with combined upregulation of heme oxygenase-1 and ferritin
C Laporte, E Tubbs, J Cristante, AS Gauchez, S Pesenti, F Lamarche, ...
Stem cell research & therapy 10, 1-12, 2019
252019
Improved human islets’ viability and functionality with mesenchymal stem cells and arg-gly-asp tripeptides supplementation of alginate micro-encapsulated islets in vitro
C Laporte, E Tubbs, M Pierron, A Gallego, A Moisan, F Lamarche, ...
Biochemical and Biophysical Research Communications 528 (4), 650-657, 2020
242020
Ten‐year outcomes of islet transplantation in patients with type 1 diabetes: Data from the Swiss‐French GRAGIL network
S Lablanche, S Borot, A Wojtusciszyn, K Skaare, A Penfornis, P Malvezzi, ...
American Journal of Transplantation 21 (11), 3725-3733, 2021
232021
Patients with highly unstable type 1 diabetes eligible for islet transplantation can be managed with a closed‐loop insulin delivery system: A series of N‐of‐1 randomized …
PY Benhamou, S Lablanche, A Vambergue, M Doron, S Franc, ...
Diabetes, Obesity and Metabolism 23 (1), 186-194, 2021
222021
A worldwide survey of activities and practices in clinical islet of Langerhans transplantation
T Berney, A Andres, MD Bellin, EJP de Koning, PRV Johnson, TWH Kay, ...
Transplant International 35, 10507, 2022
182022
Comprehensive characterization of the human pancreatic proteome for bioengineering applications
A Asthana, R Tamburrini, D Chaimov, C Gazia, SJ Walker, M Van Dyke, ...
Biomaterials 270, 120613, 2021
182021
Le système ne peut pas réaliser cette opération maintenant. Veuillez réessayer plus tard.
Articles 1–20